Stay updated on Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Sign up to get notified when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.

Latest updates to the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page
- Check6 days agoChange DetectedThe study page now displays a 403 Forbidden error page instead of the study record details, replacing content with a generic error layout and a Home button. This indicates an access restriction rather than an update to the trial information.SummaryDifference18%

- Check13 days agoChange DetectedThe page shows a new revision tag v3.7.0, replacing the previous v3.6.6. This reflects a behind-the-scenes update without changes to the study details presented on the page.SummaryDifference0.0%

- Check20 days agoNo Change Detected
- Check27 days agoChange DetectedThe page's revision indicator was updated from v3.6.5 to v3.6.6, signaling a minor backend/template update. It does not reflect changes to the study information presented on the page.SummaryDifference0.0%

- Check48 days agoChange DetectedThe page footer shows Revision: v3.6.5, replacing v3.6.4, indicating a small system revision. No substantive study information appears to be changed.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page revision was updated from v3.6.3 to v3.6.4, indicating a backend/template update. This change does not modify the study content, eligibility criteria, or user-visible information on the UP-NEXT page.SummaryDifference0.0%

- Check84 days agoChange DetectedThe page now shows a revised site version indicator (v3.6.3), replacing the previous (v3.6.2), indicating a backend update to the ClinicalTrials.gov entry.SummaryDifference0.0%

Stay in the know with updates to Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Upifitamab Maintenance in Platinum-Sensitive Recurrent Ovarian Ca Clinical Trial page.